Emily Fledderman

Emily Fledderman is a Senior Quality Assurance Specialist for Cell Therapy at AstraZeneca, a position held since September 2024. Previously, Fledderman worked as a Quality Assurance Specialist at American Gene Technologies International Inc. from October 2021 to June 2024, and served as a Staff Research Associate III at UC Davis Health System between July 2015 and May 2021, contributing to the Stem Cell Research Program. Prior experience includes roles as a Medical Technologist at UPMC's Hillman Cancer Center, a Research Assistant at the Magee-Womens Research Institute, a Student Research Assistant in the Department of Epidemiology, and a Research Assistant at the HudsonAlpha Institute for Biotechnology. Fledderman's academic background includes a Bachelor of Science in Chemistry from the University of Alabama at Birmingham, earned in 2010, and additional education at the University of Pittsburgh.